130 related articles for article (PubMed ID: 24645314)
1. [Protective effects of rhein on hepatic progression in HBV-transgenic mice with nonalcoholic steatohepatitis induced by a high-fat diet].
Bian DX; Liu J; Lu L; Liu H; Guo JC; Yang WJ; Liu YL; Luo Y; Zhuang ZJ; Chen JY; Shi JP; Xun YH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):328-31. PubMed ID: 24645314
[TBL] [Abstract][Full Text] [Related]
2. [Model building-up and observation on the mouse carried chronic hepatitis B and nonalcoholic fatty liver disease].
Lu L; Liu YL; Yang WJ; Liu J; Luo Y; Zhuang ZJ; Chen JY; Bian DX; Xun YH; Shi JP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):332-5. PubMed ID: 24645315
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice].
Zhang Z; Pan Q; Duan XY; Shi JP; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):658-63. PubMed ID: 22152379
[TBL] [Abstract][Full Text] [Related]
4. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
[TBL] [Abstract][Full Text] [Related]
5. Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.
Zhang Z; Pan Q; Duan XY; Liu Q; Mo GY; Rao GR; Fan JG
J Gastroenterol Hepatol; 2012 Dec; 27(12):1858-64. PubMed ID: 22989301
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
[TBL] [Abstract][Full Text] [Related]
7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
[TBL] [Abstract][Full Text] [Related]
9. A mouse model for nonalcoholic steatohepatitis.
Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C
J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824
[TBL] [Abstract][Full Text] [Related]
10. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
[TBL] [Abstract][Full Text] [Related]
12. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
[TBL] [Abstract][Full Text] [Related]
13. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
[TBL] [Abstract][Full Text] [Related]
14. [Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats].
Chen LL; Deng XQ; Li NX
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1434-7. PubMed ID: 17785073
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model.
Hu D; Wang H; Wang H; Wang Y; Wan X; Yan W; Luo X; Ning Q
Hepatol Int; 2018 Sep; 12(5):438-446. PubMed ID: 29974410
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
20. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]